Table 1

General characteristics of the study population, the Netherlands, in 2013–2014, 2015–2016 and 2017–2018

2013–20142015–20162017–2018
Total, n17 112 98217 269 16417 473 459
Age, mean (SD)41.76 (23.18)42.19 (23.32)42.54 (23.43)
Age categories, n (%)
 0–152 867 188 (16.75)2 815 725 (16.30)2 776 878 (15.89)
 15–252 079 263 (12.15)2 105 049 (12.19)2 138 442 (12.24)
 25–454 368 952 (25.53)4 299 213 (24.90)4 305 414 (24.64)
 45–654 755 790 (27.79)4 834 007 (27.99)4 880 562 (27.93)
 >653 041 779 (17.77)3 215 170 (18.62)3 372 163 (19.30)
Sex, n (%)
 Men8 482 826 (49.57)8 568 391 (49.62)8 679 186 (49.67)
 Women8 630 156 (50.43)8 700 773 (50.38)8 794 273 (50.33)
Received a prescription for a medication
 NSAIDs, n (%)4 094 856 (23.93)3 906 368 (22.62)3 735 730 (21.38)
 Antithrombotic agents, n (%)1 962 912 (11.47)2 033 817 (11.78)2 091 111 (11.97)
 Anticancer medication, n (%)247 017 (1.44)226 766 (1.31)223 665 (1.28)
 Systemic corticosteroids, n (%)1 243 385 (7.27)1 336 613 (7.74)1 378 921 (7.89)
 Drugs for stomach-acid disorders, n (%)2 377 506 (13.89)2 535 825 (14.68)2 603 371 (14.90)
 Antidepressants, n (%)1 223 285 (7.15)1 242 787 (7.20)1 256 602 (7.19)
 Antihypertensives, n (%)3 419 241 (19.98)3 454 098 (20.00)3 484 030 (19.94)
 Antidiabetic medication, n (%)854 240 (4.99)867 259 (5.02)877 046 (5.02)
  • All medications were identified through prescription reimbursement data, based on their ATC codes per two calendar years. Identified medication: NSAIDs (ATC code: M01A), antithrombotic agents (B01A), anticancer medication (L01, L02), systemic corticosteroids (H02A, H02B), drugs for stomach-acid related disorders (A02A, A02B, A02X), antidepressants (N06A), antihypertensives (C02, C03, C07, C08, C09), antidiabetic medication (A10). People might have received several medications in a given year, for example, could have used NSAIDs and antithrombotic agents at the same time in a given year.

  • ATC, Anatomical Therapeutic Chemical; NSAIDs, non-steroidal anti-inflammatory drugs.